This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Tabatabaei, N. Articles by Asirvatham, S. J. PubMed PubMed Citation Articles by Tabatabaei, N. Articles by Asirvatham, S. J. Related Collections Arrhythmias, clinical electrophysiology, drugs Other Treatment

Advances in Arrhythmia and Electrophysiology

Supravalvular Arrhythmia

Identifying and Ablating the Substrate

Niloufar Tabatabaei, MD and Samuel J. Asirvatham, MD

From the Department of Internal Medicine (N.T., S.J.A.), Division of Cardiovascular Diseases, and the Department of Pediatric Cardiology (S.J.A.), Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minn.

Correspondence to Samuel J. Asirvatham, MD, Division of Cardiovascular Diseases, Department of Internal Medicine and Department of Pediatric Cardiology Division of Pediatrics and Adolescent Medicine, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905 E-mail asirvatham.samuel@mayo.edu

Key Words: aortic valve • outflow tract • pulmonary arteries • pulmonary valve • radiofrequency ablation

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Mapping and ablating arrhythmias in the great arteries were rarely in the realm of consideration to treat tachyarrhythmias for the first 2 decades of invasive electrophysiology,¹ More recently, it has become clear that a variety of arrhythmias including ventricular tachycardia, atrial tachycardia, and accessory pathways can be ablated successfully in the great arteries and the cusps of the semilunar valve.^2–5

This set of arrhythmias is associated with a unique set of challenges that need to be overcome to obtain high degrees of success and avoid complications.

An understanding of substrate being mapped or ablated is important. Because of the complex relative anatomy of the cardiac valves and great arteries, the electrophysiologist must learn the exact relationship, which is not always intuitive.

Equally important is for the operator to correlate the mapped electrograms with fluoroscopy and ultrasound and to repeatedly establish in his or her mind the neighboring structures where arrhythmia may originate and avoid potentially catastrophic complications that may arise from ablation at these locations.

Important clues with regard to precise catheter location and the nature of the mapped substrate exist from the electrograms being seen at each site, as well as from details of activation mapping and pace mapping performed at each of these locations.

In this article, we will review the regional anatomy of the great arteries and semilunar valves with special emphasis on the arrhythmogenic substrate that may be present at these sites and with regard to avoiding complications as a result of collateral damage. We will . . . [Full Text of this Article]